The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

Among women aged 20 to 24 years who were screened for cervical cancer, rates decreased by 79, 80 percent for CIN2+, CIN3+.

New trends data show significant reduction in the incidence of precancerous lesions in young women since advent of vaccine.

T UESDAY, March 4, 2025 (HealthDay News) -- From 2008 to 2022, there were considerable decreases in the rates of cervical intraepithelial neoplasia (CIN) grades 2 to 3 and adenocarcinoma in situ ...

Recently, using a next-generation sequencing (NGS) technology called “Capture HPV” (135) on biopsies and circulating DNA material, five molecular signatures of HPV integration have been identified in ...

TUESDAY, March 4, 2025 (HealthDay News) -- From 2008 to 2022, there were considerable decreases in the rates of cervical intraepithelial neoplasia (CIN) grades 2 to 3 and adenocarcinoma in situ (AIS; ...

rates of cervical intraepithelial neoplasia (CIN) grades 2-3 and adenocarcinoma in situ (AIS), defined as CIN2+, decreased by 79%, and rates of CIN grade 3 and AIS, defined as CIN3+, decreased by ...

A 32-year-old woman with multiorgan metastatic cervix adenocarcinoma reported pain and blurred vision in the right eye (OD). Her vision was counts fingers with an intraocular pressure of 30 mmHg OD.

Purpose: This study aimed to assess the preoperative diagnostic efficacy of magnetic resonance imaging (MRI), computed tomography (CT), and endometrial biopsy for cervical stromal invasion (CSI) in ...